Company Profiles

driven by the PitchBook Platform

Avrobio

Avrobio
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$25M LATEST DEAL AMOUNT
$26.5M TOTAL AMOUNT RAISED
Description

Developer of transformative and life-changing gene therapies for rare diseases and cancer. The company focused on delivering step-change cell & gene therapies targeting cancer and rare disease. It also develops disruptive therapies that have the potential to transform patients' lives in a single dose.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Other Healthcare
Primary Office
400 Technology Square
10th Floor
Cambridge, MA 02139
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Avrobio’s full profile, request a free trial.

Avrobio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 30-Mar-2017 $25M $26.5M 000.00 Completed Clinical Trials - Phase 1
1. Seed Round 18-Feb-2016 00.00 00.00 000 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Avrobio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
To view this company’s complete Cap Table request access »

Avrobio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Atlas Venture Venture Capital Minority 000 0000 000000 0
Clarus Ventures Venture Capital Minority 000 0000 000000 0
SV Health Investors Venture Capital Minority 000 0000 000000 0

You’re viewing 3 of 3 investors.

Avrobio Executive Team (7)

Name Title Board
Seat
Contact
Info
Deanna Petersen Chief Business Officer
Chris Mason Ph.D Chief Science Officer
Jeffrey Medin Ph.D Co-Founder
Kim Warren Ph.D Head of Operations
Kathryn McNaughton Senior Vice President of Portfolio and Program Management
You’re viewing 5 of 7 executives. Get the full list »

Avrobio Board Members (6)

Name Representing Role Since Contact
Info
Bruce Booth Ph.D Atlas Venture Chairman of the Board of Director 000 0000
Christopher Paige Ph.D Self Co-Founder & Board Member 000 0000
Geoff MacKay Self Chief Executive Officer, President & Board Member 000 0000
Joshua Resnick MD SV Health Investors Board Member 000 0000
Michael Gladstone Atlas Venture Board Observer 000 0000
You’re viewing 5 of 6 board members. Get the full list »